Table 5 Overview of the chromosomal alterations
From: Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy
Alteration | Group B frequency | Group A frequency |
|---|---|---|
amplification 4q12 | 6/36 (17%) | 5/36 (14%) |
gain on chromosome 7 | 30/36 (83%) | 31/36 (86%) |
amplification on 7p12 | 8/36 (22%) | 6/36 (17%) |
loss on 9p | 16/36 (44%) | 18/36 (50%) |
loss on 10q | 23/36 (64%) | 25/36 (69%) |
gain on 12q | 9/36 (25%) | 6/36 (17%) |
loss of chromosome 13 | 13/36 (36%) | 21/36 (58%) |
loss of chromosome 20 | 8/36 (22%) | 9/36 (25%) |
loss of chromosome 22 | 8/36 (22%) | 7/36 (19%) |